| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:1901863 | BP | positive regulation of muscle tissue development | Any process that activates or increases the frequency, rate or extent of muscle tissue development. |
PPARGC1A |
GO:1901874 | BP | negative regulation of post-translational protein modification | Any process that stops, prevents or reduces the frequency, rate or extent of post-translational protein modification. |
CRTAP, FLCN |
GO:1901877 | BP | negative regulation of calcium ion binding | Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion binding. |
PLN |
GO:1901888 | BP | regulation of cell junction assembly | Any process that modulates the frequency, rate or extent of cell junction assembly. |
RAP1A, RAPGEF1 |
GO:1901890 | BP | positive regulation of cell junction assembly | Any process that activates or increases the frequency, rate or extent of cell junction assembly. |
FLOT1 |
GO:1901894 | BP | regulation of calcium-transporting ATPase activity | Any process that modulates the frequency, rate or extent of calcium-transporting ATPase activity. |
PLN |
GO:1901895 | BP | negative regulation of calcium-transporting ATPase activity | Any process that stops, prevents or reduces the frequency, rate or extent of calcium-transporting ATPase activity. |
PLN |
GO:1901896 | BP | positive regulation of calcium-transporting ATPase activity | Any process that activates or increases the frequency, rate or extent of calcium-transporting ATPase activity. |
RGN, RYR2 |
GO:1901897 | BP | regulation of relaxation of cardiac muscle | Any process that modulates the frequency, rate or extent of relaxation of cardiac muscle. |
PLN, CAMK2D |
GO:1901898 | BP | negative regulation of relaxation of cardiac muscle | Any process that stops, prevents or reduces the frequency, rate or extent of relaxation of cardiac muscle. |
PDE4D |
GO:1901907 | BP | diadenosine pentaphosphate catabolic process | The chemical reactions and pathways resulting in the breakdown of diadenosine pentaphosphate. |
NUDT3, NUDT10, NUDT11 |
GO:1901909 | BP | diadenosine hexaphosphate catabolic process | The chemical reactions and pathways resulting in the breakdown of diadenosine hexaphosphate. |
NUDT3, NUDT10, NUDT11 |
GO:1901911 | BP | adenosine 5'-(hexahydrogen pentaphosphate) catabolic process | The chemical reactions and pathways resulting in the breakdown of adenosine 5'-(hexahydrogen pentaphosphate). |
NUDT3, NUDT10, NUDT11 |
GO:1901962 | BP | S-adenosyl-L-methionine transmembrane transport | The directed movement of S-adenosyl-L-methionine across a membrane. |
SLC25A26 |
GO:1901964 | BP | positive regulation of cell proliferation involved in outflow tract morphogenesis | Any process that activates or increases the frequency, rate or extent of cell proliferation involved in outflow tract morphogenesis. |
BMP4 |
GO:1901970 | BP | positive regulation of mitotic sister chromatid separation | Any process that activates or increases the frequency, rate or extent of mitotic sister chromatid separation. |
ESPL1 |
GO:1901976 | BP | regulation of cell cycle checkpoint | Any process that modulates the frequency, rate or extent of cell cycle checkpoint. |
AKT1 |
GO:1901978 | BP | positive regulation of cell cycle checkpoint | Any process that activates or increases the frequency, rate or extent of cell cycle checkpoint. |
PROX1 |
GO:1901979 | BP | regulation of inward rectifier potassium channel activity | Any process that modulates the frequency, rate or extent of inward rectifier potassium channel activity. |
CAV1 |
GO:1901981 | MF | phosphatidylinositol phosphate binding | Interacting selectively and non-covalently with phosphatidylinositol phosphate. |
GAP43, PLCD1, FGD2, DENND1A, ANKFY1 |
GO:1901985 | BP | positive regulation of protein acetylation | Any process that activates or increases the frequency, rate or extent of protein acetylation. |
CAMK1 |
GO:1901989 | BP | positive regulation of cell cycle phase transition | Any process that activates or increases the frequency, rate or extent of cell cycle phase transition. |
CDCA5 |
GO:1901990 | BP | regulation of mitotic cell cycle phase transition | Any process that modulates the frequency, rate or extent of mitotic cell cycle phase transition. |
ERCC2, XPC, NEK11 |
GO:1901991 | BP | negative regulation of mitotic cell cycle phase transition | Any process that stops, prevents or reduces the frequency, rate or extent of mitotic cell cycle phase transition. |
ZFP36L2, ZFP36L1, TPRA1, RGCC |
GO:1901998 | BP | toxin transport | The directed movement of a toxin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
ARID1A, NRP1, LRP6, SLC22A3, HSPA5, TCP1, CASP1, DNAJA1, CCT3, CCT8, RAB28, ANTXR2, COPZ1, CCT2, BNIP3, ATP6V0A1, CCT7, SLC7A8, GGA1 |
GO:1902003 | BP | regulation of beta-amyloid formation | Any process that modulates the frequency, rate or extent of beta-amyloid formation. |
TMED10 |
GO:1902004 | BP | positive regulation of beta-amyloid formation | Any process that activates or increases the frequency, rate or extent of beta-amyloid formation. |
GSAP, CLU, CSNK1E, PICALM |
GO:1902010 | BP | negative regulation of translation in response to endoplasmic reticulum stress | Any process that stops, prevents, or reduces the frequency, rate or extent of translation as a result of endoplasmic reticulum stress. |
SESN2 |
GO:1902017 | BP | regulation of cilium assembly | Any process that modulates the frequency, rate or extent of cilium assembly. |
CYLD, DCDC2, VDAC3 |
GO:1902018 | BP | negative regulation of cilium assembly | Any process that stops, prevents or reduces the frequency, rate or extent of cilium assembly. |
EVI5L |
GO:1902031 | BP | regulation of NADP metabolic process | Any process that modulates the frequency, rate or extent of NADP metabolic process. |
ME2 |
GO:1902033 | BP | regulation of hematopoietic stem cell proliferation | Any process that modulates the frequency, rate or extent of hematopoietic stem cell proliferation. |
ACE |
GO:1902035 | BP | positive regulation of hematopoietic stem cell proliferation | Any process that activates or increases the frequency, rate or extent of hematopoietic stem cell proliferation. |
KITLG, PDCD2, N4BP2L2 |
GO:1902037 | BP | negative regulation of hematopoietic stem cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of hematopoietic stem cell differentiation. |
N4BP2L2 |
GO:1902038 | BP | positive regulation of hematopoietic stem cell differentiation | Any process that activates or increases the frequency, rate or extent of hematopoietic stem cell differentiation. |
FOXC1 |
GO:1902041 | BP | regulation of extrinsic apoptotic signaling pathway via death domain receptors | Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
CFLAR, LGALS3, SP100, FAS, TNFSF10, STX4, FADD, RIPK1, CASP8, TRADD, FEM1B |
GO:1902042 | BP | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
CFLAR, FGA, FGB, FGG, RAF1, SERPINE1, ICAM1, GPX1, HMOX1, HGF, TNFAIP3, FAS, HMGB2, NOS3, BRCA1, TNFSF10, DAPK1, FADD, RIPK1, CASP8, PEA15, TRADD, RFFL, ARHGEF2, TMBIM1 |
GO:1902043 | BP | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
THBS1, SKIL, MAL, STK4, FADD, PMAIP1, PEA15, SFRP1, FAF1 |
GO:1902044 | BP | regulation of Fas signaling pathway | Any process that modulates the frequency, rate or extent of Fas signaling pathway. |
SP100 |
GO:1902045 | BP | negative regulation of Fas signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of Fas signaling pathway. |
TMBIM1 |
GO:1902065 | BP | response to L-glutamate | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-glutamate stimulus. |
AIFM1, PCNA, CREB1 |
GO:1902068 | BP | regulation of sphingolipid mediated signaling pathway | Any process that modulates the frequency, rate or extent of sphingolipid signaling. |
PLPP3 |
GO:1902074 | BP | response to salt | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a salt stimulus. |
EDN1, HRSP12 |
GO:1902081 | BP | negative regulation of calcium ion import into sarcoplasmic reticulum | Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion import into sarcoplasmic reticulum. |
PLN |
GO:1902083 | BP | negative regulation of peptidyl-cysteine S-nitrosylation | Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-cysteine S-nitrosylation. |
DMD, ATP2B4, SNTA1 |
GO:1902098 | MF | calcitriol binding | Interacting selectively and non-covalently with calcitriol. Calcitriol (1,25-dihydroxycholecalciferol) is the hormonally active form of vitamin D3. |
VDR |
GO:1902108 | BP | regulation of mitochondrial membrane permeability involved in apoptotic process | Any regulation of mitochondrial membrane permeability that is involved in apoptotic process. |
THEM4 |
GO:1902109 | BP | negative regulation of mitochondrial membrane permeability involved in apoptotic process | Any negative regulation of mitochondrial membrane permeability that is involved in apoptotic process. |
NOL3 |
GO:1902115 | BP | regulation of organelle assembly | Any process that modulates the frequency, rate or extent of organelle assembly. |
EZR, RDX |
GO:1902118 | MF | calcidiol binding | Interacting selectively and non-covalently with calcidiol. |
GC |
GO:1902121 | MF | lithocholic acid binding | Interacting selectively and non-covalently with lithocholic acid. |
VDR |
GO:1902122 | MF | chenodeoxycholic acid binding | Interacting selectively and non-covalently with chenodeoxycholic acid. |
NR1H4 |
GO:1902161 | BP | positive regulation of cyclic nucleotide-gated ion channel activity | Any process that activates or increases the frequency, rate or extent of cyclic nucleotide-gated ion channel activity. |
CFTR |
GO:1902166 | BP | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator. |
TRIAP1, KDM1A, CD74, MIF, MUC1, CD44, BCL2L12, TAF9B |
GO:1902170 | BP | cellular response to reactive nitrogen species | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive nitrogen species stimulus. |
MAP3K5 |
GO:1902172 | BP | regulation of keratinocyte apoptotic process | Any process that modulates the frequency, rate or extent of keratinocyte apoptotic process. |
ZFP36, ZFP36L1 |
GO:1902173 | BP | negative regulation of keratinocyte apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of keratinocyte apoptotic process. |
SERPINB13 |
GO:1902174 | BP | positive regulation of keratinocyte apoptotic process | Any process that activates or increases the frequency, rate or extent of keratinocyte apoptotic process. |
SFRP4 |
GO:1902175 | BP | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | Any process that modulates the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. |
P4HB |
GO:1902176 | BP | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. |
NOL3, VNN1, INS, SOD2, HSPB1, GPX1, AKT1, MAPK7, BAG5 |
GO:1902177 | BP | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. |
SFPQ |
GO:1902186 | BP | regulation of viral release from host cell | Any process that modulates the frequency, rate or extent of viral release from host cell. |
TRIM25, TRIM62 |
GO:1902187 | BP | negative regulation of viral release from host cell | Any process that stops, prevents or reduces the frequency, rate or extent of viral release from host cell. |
TRIM13, TRIM26, TRIM28, TRIM25, TRIM8, TRIM35 |
GO:1902188 | BP | positive regulation of viral release from host cell | Any process that activates or increases the frequency, rate or extent of viral release from host cell. |
CHMP2A, VPS4B, CHMP4B |
GO:1902202 | BP | regulation of hepatocyte growth factor receptor signaling pathway | Any process that modulates the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway. |
PTPN2 |
GO:1902203 | BP | negative regulation of hepatocyte growth factor receptor signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway. |
ADAMTS12 |
GO:1902204 | BP | positive regulation of hepatocyte growth factor receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway. |
ESM1 |
GO:1902206 | BP | negative regulation of interleukin-2-mediated signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-2-mediated signaling pathway. |
PTPN2 |
GO:1902212 | BP | negative regulation of prolactin signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of prolactin signaling pathway. |
PTPN2 |
GO:1902213 | BP | positive regulation of prolactin signaling pathway | Any process that activates or increases the frequency, rate or extent of prolactin signaling pathway. |
CREBRF |
GO:1902215 | BP | negative regulation of interleukin-4-mediated signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-4-mediated signaling pathway. |
PTPN2 |
GO:1902219 | BP | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to osmotic stress. |
ARHGEF2 |
GO:1902227 | BP | negative regulation of macrophage colony-stimulating factor signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of macrophage colony-stimulating factor signaling pathway. |
PTPN2 |
GO:1902230 | BP | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage. |
SNAI2, CLU, TPT1, CXCL12, CCAR2 |
GO:1902231 | BP | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage | Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage. |
SKIL, FBXO18, RAD9A |
GO:1902233 | BP | negative regulation of positive thymic T cell selection | Any process that stops, prevents or reduces the frequency, rate or extent of positive thymic T cell selection. |
PTPN2 |
GO:1902235 | BP | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Any process that modulates the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. |
ERP29 |
GO:1902236 | BP | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. |
PARK2, OPA1, HSPA1A, HSPA1B, XBP1, GRINA, SYVN1, CREB3L1, VIMP |
GO:1902237 | BP | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. |
BCL2L11, PTPN2, DDIT3, SERINC3, PMAIP1 |
GO:1902254 | BP | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway by p53 class mediator. |
PARK2, PTTG1IP, RRN3 |
GO:1902256 | BP | regulation of apoptotic process involved in outflow tract morphogenesis | Any process that modulates the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis. |
TGFB2 |
GO:1902257 | BP | negative regulation of apoptotic process involved in outflow tract morphogenesis | Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis. |
FOXC1 |
GO:1902259 | BP | regulation of delayed rectifier potassium channel activity | Any process that modulates the frequency, rate or extent of delayed rectifier potassium channel activity. |
VAMP2, KCNG1 |
GO:1902260 | BP | negative regulation of delayed rectifier potassium channel activity | Any process that stops, prevents or reduces the frequency, rate or extent of delayed rectifier potassium channel activity. |
ANK3 |
GO:1902261 | BP | positive regulation of delayed rectifier potassium channel activity | Any process that activates or increases the frequency, rate or extent of delayed rectifier potassium channel activity. |
AKAP6 |
GO:1902262 | BP | apoptotic process involved in patterning of blood vessels | Any apoptotic process that is involved in patterning of blood vessels. |
LRP5, BAX |
GO:1902263 | BP | apoptotic process involved in embryonic digit morphogenesis | Any apoptotic process that is involved in embryonic digit morphogenesis. |
BCL2L11, NOTCH1, BAX |
GO:1902268 | BP | negative regulation of polyamine transmembrane transport | Any process that stops, prevents or reduces the frequency, rate or extent of polyamine transmembrane transport. |
OAZ2, OAZ1 |
GO:1902269 | BP | positive regulation of polyamine transmembrane transport | Any process that activates or increases the frequency, rate or extent of polyamine transmembrane transport. |
AZIN1 |
GO:1902275 | BP | regulation of chromatin organization | Any process that modulates the frequency, rate or extent of chromatin organization. |
MKI67 |
GO:1902282 | MF | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization | Enables the transmembrane transfer of a potassium ion by a voltage-gated channel through the plasma membrane of a ventricular cardiomyocyte contributing to the repolarization phase of an action potential. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded. |
KCNH2 |
GO:1902283 | BP | negative regulation of primary amine oxidase activity | Any process that stops, prevents or reduces the frequency, rate or extent of primary amine oxidase activity. |
PARK2 |
GO:1902285 | BP | semaphorin-plexin signaling pathway involved in neuron projection guidance | Any semaphorin-plexin signaling pathway that is involved in neuron projection guidance. |
NRP1, NRP2, SEMA3A |
GO:1902287 | BP | semaphorin-plexin signaling pathway involved in axon guidance | Any semaphorin-plexin signaling pathway that is involved in axon guidance. |
NRP1, PLXNB2, PLXNC1, PLXNA2, PLXNA3, SEMA3A, PLXNA1, PLXND1 |
GO:1902303 | BP | negative regulation of potassium ion export | Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion export. |
KCNH2 |
GO:1902304 | BP | positive regulation of potassium ion export | Any process that activates or increases the frequency, rate or extent of potassium ion export. |
ANO6 |
GO:1902305 | BP | regulation of sodium ion transmembrane transport | Any process that modulates the frequency, rate or extent of sodium ion transmembrane transport. |
ATP2B4, FGF12, DLG1, SNTA1, RANGRF |
GO:1902306 | BP | negative regulation of sodium ion transmembrane transport | Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transport. |
CAMK2D, COMMD1, NEDD4L |
GO:1902307 | BP | positive regulation of sodium ion transmembrane transport | Any process that activates or increases the frequency, rate or extent of sodium ion transmembrane transport. |
ARF1 |
GO:1902309 | BP | negative regulation of peptidyl-serine dephosphorylation | Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-serine dephosphorylation. |
YWHAE |